课题基金 / 基金详情

A new enzyme in cardiolipin synthesis

A new enzyme in cardiolipin synthesis
心磷脂合成中的新酶
批准号:
RGPIN-2019-05642
负责人:
Duncan, Robin
金额:
$3.64万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2021
资助国家:
加拿大
项目状态:
已结题
起止时间:
2021-01-01 至 2022-12-31

项目摘要

项目成果

Duncan, Robin的其他基金

相似基金

相关文献

中文摘要
翻译
心磷脂是构成线粒体内层的一种特殊脂肪,线粒体被认为是细胞的“动力源”。心磷脂存在于每个器官中,但在不同的器官中有不同形式的心磷脂。因为不同的部位需要特定形式的心磷脂,不同的器官有特殊的小机器,叫做酶,它们用来将心磷脂从一种形式转化为另一种形式,并在需要时制造更多的心磷脂。这种心磷脂的“重塑”对健康很重要。当身体没有产生足够的心磷脂,或者当身体没有产生正确类型的心磷脂时,就会导致疾病。事实上,心磷脂数量和类型的变化通常发生在衰老过程中,也发生在许多不同的疾病中,如阿尔茨海默病和帕金森病、心脏病和中风、心血管疾病和糖尿病。还有一些遗传疾病,孩子出生时重塑心磷脂的能力很差,这可能会导致心力衰竭等严重后果。我们发现了一种可以重塑心磷脂的新酶。我们对此感到非常兴奋,因为这是近10年来首次发现此类新发现。我们也很兴奋,因为之前的一些发现是加拿大人发现的,这意味着我们可以帮助加拿大成为这一领域的全球领导者。大脑中有很多这种酶,心脏和肌肉中也有很多,这些都是需要大量能量的组织。脂肪中也有一些,这是令人兴奋的,因为脂肪中能量产生的变化会影响体重增加。为了进一步了解这种酶是如何工作的,以及它在体内的作用,我们将在细胞中研究它,并将其分离提纯。这让我们可以测试它的工作效果,它产生的特定类型的心磷脂,以及改变这些形式如何改变细胞产生能量的能力。这将告诉我们很多关于这种新酶的信息,也会告诉我们细胞是如何工作的。我们还将研究它在人体内的作用。正常情况下,人类和老鼠有两份DNA副本,其中包含制造这种酶的蓝图。我们制造了一种特殊的老鼠,它缺少其中一个拷贝。我们要让这些老鼠一起繁殖,这样我们就能制造出没有任何副本的老鼠。我们在测试小鼠的正常功能和疾病方面有很多经验。我们将对这些特殊的老鼠进行研究,看看失去这种酶对它们有多大影响。我们要研究他们的大脑,看看他们是否有记忆问题,以及控制学习的细胞和分子是否有问题。我们还将研究他们的肌肉和脂肪,看看这是否会改变他们的工作效率。这些信息将帮助我们了解人类的功能,这对健康和疾病很重要。
英文摘要
Cardiolipin is a special type of fat that makes up the inside lining of the mitochondria, which are considered the `powerhouses' of the cell. Cardiolipin is found in every organ, but there are different forms of cardiolipin in different organs. Because specific forms of cardiolipin are needed in different places, different organs have special little machines, called enzymes, that they use to convert cardiolipin from one form to another, and to make more when it is needed. This `remodeling' of cardiolipin is important for health. When the body doesn't make enough cardiolipin, or when the body doesn't make the right types of cardiolipin, diseases can result. In fact, changes in cardiolipin amount and type commonly occur in aging, and also in many different diseases, such as Alzheimer's and Parkinson's diseases, heart disease and stroke, cardiovascular disease, and diabetes. There are also genetic diseases, where children are born with a poor ability to remodel cardiolipin, and it can cause serious consequences like heart failure. We have discovered a new enzyme that remodels cardiolipin. We are very excited about this, since it is the first new discovery of its kind in almost 10 years. We are also excited because some of the previous discoveries have been by Canadians, which means that we can help to make Canada a global leader in this field. There is a lot of this enzyme in the brain, and also in the heart and muscle which are all very energetic tissues that need to make a lot of power. There is also some in the fat, which is exciting, because changes in energy production in fat can affect weight gain. To find out more about how this enzyme works, and what it does in the body, we are going to study it in cells, and also make it in an isolated, purified form. This lets us let test how well it works, what specific types of cardiolipin it makes, and how changing those forms changes how well cells can work to make energy. This will tells us a lot about this new enzyme, but also about how cells work. We are also going to study what it does in the body. Normally, humans and mice have two copies of DNA that contains the blueprint for making this enzyme. We have made special mice that are missing one of those copies. We are going to breed the mice together, so that we make mice that don't have any copies. We have a lot of experience testing mice for normal function, and for disease. We are going to study these special mice to see how much they are affected by losing this enzyme. We are going to study their brains, to see if they have memory problems, and problems with the cells and molecules that control learning. We will also study their muscle and fat, to see if it changes how well they work. This information will help us to understand how humans function, which is important for health and disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A new enzyme in cardiolipin synthesis
  • 批准号:
    RGPIN-2019-05642
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.64万
  • 财政年份:
    2022
  • 负责人:
    Duncan, Robin
  • 依托单位:
A new enzyme in cardiolipin synthesis
  • 批准号:
    RGPIN-2019-05642
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.64万
  • 财政年份:
    2020
  • 负责人:
    Duncan, Robin
  • 依托单位:
A new enzyme in cardiolipin synthesis
  • 批准号:
    RGPAS-2019-00008
  • 项目类别:
    Discovery Grants Program - Accelerator Supplements
  • 资助金额:
    $5.83万
  • 财政年份:
    2020
  • 负责人:
    Duncan, Robin
  • 依托单位:
A new enzyme in cardiolipin synthesis
  • 批准号:
    RGPIN-2019-05642
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.64万
  • 财政年份:
    2019
  • 负责人:
    Duncan, Robin
  • 依托单位:
国内基金
海外基金
酶响应的中性粒细胞外泌体载药体系在眼眶骨缺损修复中的作用及机制研究
  • 批准号:
    82371102
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    苏蕴
  • 依托单位:
PCBP1和PCBP2调控cGAS的相变和酶活的机制研究
  • 批准号:
    32370928
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2023
  • 负责人:
    孙钦秒
  • 依托单位:
蛋白精氨酸甲基化转移酶PRMT5调控PPARG促进巨噬细胞M2极化及其在肿瘤中作用的机制研究
  • 批准号:
    82371738
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    郑英霞
  • 依托单位:
木质纤维素高效水解多酶混合物(multi-enzyme cocktails)的高通量分析及其理性定制
  • 批准号:
    21176106
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2011
  • 负责人:
    孙付保
  • 依托单位: